Aria Pharmaceuticals
About this raise
Aria Pharmaceuticals, with a valuation of $85 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed an AI-driven drug delivery platform for therapeutic development candidates. The software platform helps in identifying promising hits, derisking the opportunities through preclinical studies, and progressing drug candidates to clinical trials. Aria Pharmaceuticals has already modeled over 300 diseases and has identified 1,000 diseases that it could address. Andrew A. Radin founded Aria Pharmaceuticals in 2014. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $2,510,000. The campaign proceeds will be used for growth and expansion.
Investment Overview
Deal Terms
- Platform
- OurCrowd
- Start Date
- 09/13/2021
- Close Date
- 10/21/2021
$10,000
$2,510,000
$10,000
Convertible Note
Growth Stage
RegD 506(c)
$85,000,000
0%
Company & Team
Company
- Year Founded
- 2014
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Palo Alto, California
- Company Website
-
Visit Website
Team
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 10/21/2021 | OurCrowd | $85,000,000 | - | Convertible Note | Funded | RegD 506(c) |